Jefferies Financial Group’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-525,600
Closed -$1.96M 2080
2024
Q4
$1.96M Hold
525,600
0.01% 674
2024
Q3
$2.94M Sell
525,600
-56,500
-10% -$395K 0.02% 463
2024
Q2
$4.9M Buy
582,100
+309,700
+114% +$3.3M 0.05% 296
2024
Q1
$3.93M Buy
272,400
+67,400
+33% +$1.11M 0.04% 370
2023
Q4
$4.41M Buy
205,000
+55,200
+37% +$985K 0.03% 438
2023
Q3
$2.88M Buy
149,800
+78,800
+111% +$1.68M 0.03% 504
2023
Q2
$1.8M Buy
71,000
+11,000
+18% +$318K 0.02% 695
2023
Q1
$2.17M Hold
60,000
0.02% 636
2022
Q4
$2.38M Buy
+60,000
New +$2.49M 0.02% 599

Other funds holding NVRO

Jefferies Financial Group's NVRO Position: Q1 2025 in Review

Jefferies Financial Group sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 441,903 shares — an estimated $1.64M sold.

Jefferies Financial Group first reported a position in NVRO in Q4 2022 and held it in 9 quarters. The position peaked at $2.32M in Q2 2024. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • Jefferies Financial Group reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 441,903 NEVRO CORP. shares in Q1 2025, an estimated $1.64M.
  • Jefferies Financial Group first reported a position in NEVRO CORP. in Q4 2022 and held it in 9 quarters.
  • Jefferies Financial Group's NEVRO CORP. position peaked at $2.32M in Q2 2024.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Jefferies Financial Group's 13F filing for Q1 2025, filed 8 May 2025.